| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | HEALTHEQUITY INC | 175,375 | 5,329,000 | 1.58% | ||
| 152 | LOGMEIN INC | 89,380 | 5,669,000 | 1.68% | ||
| 153 | EAGLE BANCORP INC MD | 119,978 | 5,772,000 | 1.72% | ||
| 154 | ABIOMED INC | 53,630 | 5,861,000 | 1.74% | ||
| 155 | MAXLINEAR INC COM | 327,810 | 5,894,000 | 1.75% | ||
| 156 | CAMBREX CORP | 114,795 | 5,938,000 | 1.76% | ||
| 157 | COOPER STD HLDGS INC | 84,330 | 6,661,000 | 1.98% | ||
| 158 | AMN HEALTHCARE SERVICES INC | 175,090 | 6,998,000 | 2.08% | ||
| 159 | DIAMONDBACK ENERGY INC | 77,680 | 7,085,000 | 2.11% | ||
| 160 | INOGEN INC COM | 142,720 | 7,152,000 | 2.13% | ||
| 161 | TAL ED GROUP | 130,360 | 8,090,000 | 2.40% | ||
| 162 | DIPLOMAT PHARMACY INC COM | 237,515 | 8,313,000 | 2.47% | ||
| 163 | CHINA BIOLOGIC PRODS INC | 82,775 | 8,801,000 | 2.62% | ||
| 164 | Callidus Software Inc | 457,649 | 9,144,000 | 2.72% | ||
| 165 | STAMPS COM INC COM NEW | 107,330 | 9,383,000 | 2.79% | ||
| 166 | INPHI CORPORATION | 305,175 | 9,775,000 | 2.91% | ||
| 167 | LIGAND PHARMACEUTICALS INC | 84,442 | 10,071,000 | 2.99% | ||
| 168 | DEXCOM INC | 133,175 | 10,565,000 | 3.14% | ||
| 169 | GIGAMON INC | 285,270 | 10,666,000 | 3.17% | ||
| 170 | COTT CORP QUE | 2,410,153 | 33,646,000 | 10.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119055, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
